Análisis farmacoeconómico de Metoject® en el tratamiento de la artritis reumatoide en España

Original

Pharmacoeconomic analysis of Metoject® in the treatment of rheumatoid arthritis in Spain

Carlos Crespoa,b,

Corresponding author

carlos.crespo@oblikue.com

Autor para correspondencia.

, Max Brosaa, Jordi Galvánc, Jordi Carbonelld,e, Jordi Maymód,e, J.L.. José Luis Marencof, Javier del Pino-Montesg, Alberto Alonsoh, Carlos Rodríguezi

a Oblikue Consulting, Barcelona, España

b Departamento de Estadística, Universidad de Barcelona, Barcelona, España

c Departamento Médico, Laboratorios Gebro Pharma, Barcelona, España

d Hospital del Mar, Barcelona, España

e Hospital de la Esperanza, Barcelona, España

f Hospital Universitario de Valme, Sevilla, España

g Hospital Universitario de Salamanca, Salamanca, España

h Hospital de Cruces, Bilbao, España

i Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas, España

Read

17070

Times
was read the article

3609

Total PDF

13461

Total HTML

Share statistics

Article information

ISSN: 1699258X
Original language: Spanish

DOI:10.1016/j.reuma.2009.11.001

The statistics are updated each day

Year/Month	Html	Pdf	Total

2025 6	8	17	25
2025 5	192	73	265
2025 4	188	47	235
2025 3	129	35	164
2025 2	107	35	142
2025 1	106	59	165
2024 12	100	36	136
2024 11	133	61	194
2024 10	125	33	158
2024 9	101	25	126
2024 8	111	50	161
2024 7	104	48	152
2024 6	118	37	155
2024 5	116	26	142
2024 4	99	18	117
2024 3	89	33	122
2024 2	92	32	124
2024 1	61	28	89
2023 12	60	25	85
2023 11	80	30	110
2023 10	98	32	130
2023 9	142	33	175
2023 8	45	22	67
2023 7	70	24	94
2023 6	79	35	114
2023 5	67	38	105
2023 4	59	16	75
2023 3	94	25	119
2023 2	71	32	103
2023 1	65	17	82
2022 12	108	32	140
2022 11	90	39	129
2022 10	112	51	163
2022 9	77	37	114
2022 8	72	42	114
2022 7	61	47	108
2022 6	59	34	93
2022 5	61	56	117
2022 4	48	54	102
2022 3	75	52	127
2022 2	63	28	91
2022 1	69	37	106
2021 12	69	50	119
2021 11	60	52	112
2021 10	110	48	158
2021 9	57	54	111
2021 8	37	46	83
2021 7	34	37	71
2021 6	41	48	89
2021 5	82	57	139
2021 4	116	121	237
2021 3	84	43	127
2021 2	59	31	90
2021 1	52	30	82
2020 12	67	23	90
2020 11	67	31	98
2020 10	49	22	71
2020 9	71	59	130
2020 8	53	39	92
2020 7	66	25	91
2020 6	93	24	117
2020 5	81	35	116
2020 4	62	24	86
2020 3	83	22	105
2020 2	65	21	86
2020 1	64	31	95
2019 12	100	28	128
2019 11	67	20	87
2019 10	72	17	89
2019 9	114	39	153
2019 8	103	17	120
2019 7	124	18	142
2019 6	165	26	191
2019 5	196	67	263
2019 4	145	35	180
2019 3	112	21	133
2019 2	89	28	117
2019 1	57	28	85
2018 12	96	54	150
2018 11	93	13	106
2018 10	81	13	94
2018 9	61	9	70
2018 8	55	13	68
2018 7	24	5	29
2018 5	8	3	11
2018 4	70	3	73
2018 3	91	6	97
2018 2	67	4	71
2018 1	53	7	60
2017 12	71	11	82
2017 11	75	5	80
2017 10	28	9	37
2017 9	49	8	57
2017 8	81	8	89
2017 7	85	5	90
2017 6	71	11	82
2017 5	110	13	123
2017 4	123	7	130
2017 3	146	27	173
2017 2	118	5	123
2017 1	136	8	144
2016 12	160	10	170
2016 11	186	13	199
2016 10	228	11	239
2016 9	301	14	315
2016 8	198	10	208
2016 7	108	11	119
2016 5	3	0	3
2015 12	3	15	18
2015 11	2	9	11
2015 10	11	24	35
2015 9	3	0	3
2015 8	3	12	15
2015 7	96	10	106
2015 6	136	10	146
2015 5	184	14	198
2015 4	129	15	144
2015 3	141	5	146
2015 2	185	6	191
2015 1	156	11	167
2014 12	138	13	151
2014 11	142	12	154
2014 10	111	10	121
2014 9	85	9	94
2014 8	131	5	136
2014 7	142	9	151
2014 6	145	12	157
2014 5	188	14	202
2014 4	138	11	149
2014 3	125	16	141
2014 2	115	13	128
2014 1	131	10	141
2013 12	108	14	122
2013 11	80	12	92
2013 10	113	16	129
2013 9	78	12	90
2013 8	73	12	85
2013 7	67	6	73
2013 6	60	15	75
2013 5	57	8	65
2013 4	66	5	71
2013 3	66	11	77
2013 2	45	8	53
2013 1	39	8	47
2012 12	42	6	48
2012 11	27	25	52
2012 10	24	11	35
2012 9	15	11	26
2011 5	1	0	1
2011 4	2	0	2
2011 3	4	0	4
2011 2	28	0	28
2011 1	5	0	5
2010 12	10	0	10
2010 11	35	0	35
2010 10	3	0	3
2010 9	2	0	2
2010 8	3	0	3
2010 7	19	0	19
2010 6	3	0	3

Show all

Indexed in:

Follow us:

Subscribe:

Statistics

Indexed in:

Follow us:

Subscribe:

Statistics

Subscribe to our newsletter